Aegis Capital Starts Navidea Biopharmaceuticals (NAVB) at Hold
Tweet
Share
E-mailGet Alerts NAVB Hot Sheet
Price: $0.00 --0%
Rating Summary:
4 Buy, 2 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
4 Buy, 2 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Earlier, Aegis Capital initiates coverage on Navidea Biopharmaceuticals (NYSE: NAVB) with a Hold. PT $3.00.
NOTE: Burrill started at a Market Outperform today.
For an analyst ratings summary and ratings history on Navidea Biopharmaceuticals click here. For more ratings news on Navidea Biopharmaceuticals click here.
Shares of Navidea Biopharmaceuticals closed at $2.97 yesterday.
NOTE: Burrill started at a Market Outperform today.
For an analyst ratings summary and ratings history on Navidea Biopharmaceuticals click here. For more ratings news on Navidea Biopharmaceuticals click here.
Shares of Navidea Biopharmaceuticals closed at $2.97 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Needham Starts Faeth Therapeutics (FTH) at Buy
- Wells Fargo Starts Vivmark Residential (VMRK) at Overweight, 'Setting the mark for growth'
- William Blair Starts Tandem Diabetes Care (TNDM) at Outperform
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
